Kliniske studier for Myositt i Georgia
3 studier for Myositt søker deltakere på steder i Georgia.
Offisiell studietekst (engelsk)
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Healthcare of Atlanta - Accepting Juvenile Patients, Atlanta
- Emory University - Accepting Adult Patients, Atlanta
RekruttererFase 2/3
Alder 6 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Emory University School of Medicine: Division of Rheumatology, Atlanta
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07103746AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Gainesville, Gainesville
- Artiva Investigational Site Norcross, Norcross
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT06991114Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.